Idexx Laboratories INC IDEXX LABORATORIES ORD SHS
Idexx Laboratories INC IDEXX LABO.../ US45168D1046 /
0J8P
29/04/2024 15:51:59
|
Chg.
-
|
Volume |
Bid06:00:05 |
Ask06:00:05 |
Market Capitalization |
Dividend Y. |
P/E Ratio |
506.01USD
|
-
|
2,996 Turnover: 22,770.45 |
-Bid Size: - |
-Ask Size: - |
38.79 bill.USD |
- |
46.19 |
Fundamentals
|
FY 2023 |
Growth (1Y) |
Per Share |
|
Earnings per Share: |
10.17 USD |
25.25% |
EPS Diluted: |
10.06 USD |
25.28% |
Revenues per Share: |
44.06 USD |
8.48% |
Book Value per Share: |
17.87 USD |
143.32% |
Cash Flow per Share: |
10.91 USD |
66.58% |
Dividend per Share: |
- USD |
- |
Total |
in mill. |
|
Revenues: |
3,660.95 USD |
8.72% |
Net Income: |
845.04 USD |
24.44% |
Operating Cash Flow: |
906.51 USD |
- |
Cash and Cash Equivalents: |
453.93 USD |
- |
Valuation Ratios
|
Current |
Latest FY* |
P/E Ratio: |
46.19 |
54.58 |
P/S Ratio: |
10.66 |
12.60 |
P/BV ratio: |
26.29 |
31.07 |
P/CF Ratio: |
43.05 |
50.88 |
PEG: |
1.83 |
2.16 |
Earnings Yield: |
2.17% |
1.83% |
Dividend Yield: |
- |
- |
Market Capitalization |
|
Market Capitalization: |
38.79 bill. USD |
46.12 bill. USD |
Free Float Market Cap.: |
- USD |
- USD |
Market Cap. / Employee: |
- USD |
- USD |
Shares Outstanding: |
82.59 mill. |
|
Profitability
Gross Profit Margin: |
59.82% |
EBIT Margin: |
29.97% |
Net Profit Margin: |
23.08% |
Return on Equity: |
56.92% |
Return on Assets: |
25.92% |
Financial Strength
Liquidity I / Cash Ratio: |
47.70% |
Liquidity II / Quick Ratio: |
95.78% |
Liquidity III / Current Ratio: |
157.14% |
Debt / Equity Ratio: |
119.59% |
Dynam. Debt / Equity Ratio: |
195.85% |
Efficiency
Employees: |
- |
Personal Expenses / Employee: |
- USD |
Revenues / Employee: |
- USD |
Net Income / Employee: |
- USD |
Total Assets / Employee: |
- USD |
* Fiscal Year End: |
31/12/2023 |
Accounting Standard: |
US GAAP |